By Chijioke Ohuocha and Praveen Menon

Sovereign fund Investment Corp of Dubai (ICD) has bought a 1.4 percent stake in Dangote Cement, Nigeria's biggest company by market capitalisation, for $300 million, a Dangote spokesman said on Monday.

Dangote Cement spokesman Carl Franklin confirmed the sale, but provided no further details.

Stockbrokers in Lagos told Reuters 243 million shares of Dangote Cement were transferred to ICD, which holds stakes in some of the emirate's top companies, at 200 naira each, a 12 percent premium to Dangote Cement's price of around 223 naira on Monday.

"ICD is diversifying its portfolio ... into the West African market through a minority stake in Dangote Cement. We believe this bodes well for future investments into Nigeria from the Middle East," Akinbamidele Akintola, an Africa equity sales executive at Renaissance Capital, said.

Dangote Cement, owned by Africa's richest man Aliko Dangote, is expanding and plans to roll out cement plants across Africa to reach an annual 62 million tonnes capacity by 2017, up from a projected 42 million tonnes this year.

It reported pretax profit of 107.1 billion naira ($659.4 million) in the first half, down 0.57 percent from a year ago, on revenues of 208.9 billion naira.

Shares in Dangote cement, which make up a third of Nigeria's stock market and hit a record high of 250 naira in July, traded flat at 223 naira on Monday, valuing Nigeria's biggest company at about 3.97 trillion naira ($24.5 billion).

Dangote Cement faces competition in Africa from French cement maker Lafarge which is combining its Nigerian and South African businesses to accelerate growth on the continent.

Last year, Dangote Industries sold a 1.5 percent of its 95 percent stake in Africa's biggest cement producer to South Africa's Public Investment Corporation (PIC) for $289.3 million.

Middle East companies are expanding in Africa. Last week, Qatar National Bank (QNB) bought a 12.5 percent stake in pan-African lender Ecobank for about $200 million.

 

Related Articles

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

R&T, WongP, Lee & Lee advise on $595 mln TCM deal

by Nimitt Dixit |

Singapore law firms WongPartnership, Lee & Lee and Rajah & Tann (R&T), and R&T’s Malaysian member firm Christopher & Lee Ong have advised traditional Chinese medicine firm Eu Yan Sang International (EYS) and its shareholders on the sale of 86 percent of EYS’ shares.

Skadden advises Cemex on $650 mln Philippines divestment

by Nimitt Dixit |

U.S. law firm Skadden, Arps, Slate, Meagher & Flom has advised Mexico-based multinational building materials company Cemex on the sale of its operations and assets in the Philippines to Dacon Corporation, DMCI Holdings, and Seminara Mining and Power Corporation.